Pathobiont expansion, such as that of adherent-invasive Escherichia coli (AIEC), is an emerging factor associated with inflammatory bowel disease. The intestinal epithelial barrier is the first line of defense against these pathogens. Inflammation plays a critical role in altering the epithelial barrier and is a major factor involved in promoting the expansion and pathogenesis of AIEC. AIEC in turn can exacerbate intestinal epithelial barrier dysfunction by targeting multiple elements of the barrier. One critical element of the epithelial barrier is the tight junction. Increasing evidence suggests that AIEC may selectively target protein components of tight junctions, leading to increased barrier permeability. This may represent one mechanism by which AIEC could contribute to the development of inflammatory bowel disease. This review article discusses potential mechanisms by which AIEC can disrupt epithelial tight junction function and intestinal barrier function. I nflammation plays a major role in altering the intestinal microenvironment, including the intestinal microbiome, and can result in the promotion of pathobiont expansion. 1 A clinically important example of this involves the expansion of the adherent-invasive Escherichia coli (AIEC) LF82, originally isolated from ileal mucosa of a Crohn's disease patient. 2 Crohn's disease (CD) and ulcerative colitis (UC) are multifaceted conditions that collectively are referred to as inflammatory bowel disease (IBD). 3, 4 Factors contributing to IBD onset and development include dysregulation of gut bacteria and an increase in intestinal epithelial barrier permeability. 1 This review article discusses the emergence of AIEC as a potential pathogenic factor in IBD and the molecular mechanisms through which it disrupts intestinal epithelial homeostasis and tight junction (TJ) integrity.
AIEC
Although the etiology of IBD is unknown, many investigators have probed whether a pathogenic cause can be attributed to onset of disease, either in full or in part. [5] [6] [7] Although no pathogen has been shown consistently to be associated with IBD, a subset of CD patients do show increased prevalence of a unique enteropathogenic strain of the B2 phylotype E coli termed AIEC. 2, 8, 9 Ileal biopsy specimens from CD and UC patients have shown that AIEC are associated primarily with CD; however, more recent studies have shown an equal prevalence of AIEC strains in UC as well as CD, suggesting that this pathobiont may have a greater association with IBD than first thought. [10] [11] [12] Although LF82 is the most referenced AIEC, it is only one of many AIEC strains that were found in IBD patients. 2, 13 It has been remarkably difficult to identify a specific genetic or molecular marker of AIEC, thus in vitro assays are used to validate AIEC.
14 However, there may be some genetic signatures that differ between the B2 AIEC phylotype compared with other AIEC phylotypes. 12 One potential AIEC candidate gene is the novel AIEC serine protease Vat-AIEC, which promotes expansion and adherence of AIEC to intestinal epithelial cells (IECs). 15 Expression of this gene was approximately 3-fold higher in CD-AIEC isolates compared with non-AIEC isolates from CD patients or healthy subjects. 15 It therefore could be considered a selective rather than an exclusive genetic marker for AIEC.
AIEC are distinct from other strains of E coli because they show nonclassic virulence factors of adherence and invasion (ie, lack of a type III secretion system). 13 Notably, AIEC pathogenesis involves survival and replication in IECs and macrophages in vivo and in vitro that further exacerbated barrier dysfunction, this topic is discussed later (Figure 1) . 9, 13 Martinez-Medina and Garcia-Gil 16 published an excellent comprehensive review on the definition, characteristics, and molecular basis of AIEC pathogenicity.
Interaction of AIEC With IECs
The intestine is lined by a single layer of epithelial cells that are interconnected by transmembrane proteins to create physical connections with one another and to form a selectively permeable barrier. 17 This leaky barrier serves multiple ). Disruption of barrier function can lead to loss of microbiome diversity and promotion of AIEC expansion and pathogenesis. 1, 6 IECs express molecular sensors that sample the luminal content for bacterial antigens, and in some cases the bacteria itself, and translate this information to host immune cells. 19 This process prevents the host immune system from a robust proinflammatory response against commensal bacteria while maintaining the ability to protect against pathogens. The first identified IBD-associated gene, cytoplasmic nucleotide-binding oligomerization domain 2 (NOD2/ CARD15), a NOD-like receptor family member, serves as a sensor to bacterial peptidoglycans (BPs) (reviewed by Philpott et al 20 )
. Binding of BPs to NOD2 results in the activation of nuclear factor-kB (NF-kB) and autophagolysis, 21 and the appearance of NOD2 at the site of bacterial endocytosis in epithelial cells drives autophagolysis. 20 Mutations in NOD2 result in an increased immune response to bacteria and bacterial antigens 22 that is accompanied by impaired autophagolysis of AIEC and subsequently survival of AIEC in immune cells. 23, 24 Conversely, overexpression of NOD2 and other genes involved in autophagy (eg, by activation of the eukaryotic translation initiation factor 2 alpha kinase 4-eukaryotic translation initiation factor 2 alpha-activating transcription factor 4 [EIF2AK4-EIF2A-ATF4] pathway), results in an increased autophagy response to AIEC and a reduction in AIEC survival in macrophages. [25] [26] [27] Thus, functional autophagolysis in both intestinal epithelial cells and macrophages is required for AIEC degradation and prevention of AIEC-induced barrier dysfunction. 24 It is clear that proinflammatory cytokine signaling plays a major role in altered intestinal permeability 28 and this may be associated with AIEC pathogenesis. Loss of negative regulation of proinflammatory cytokines (eg, interferon-g [IFN-g] and tumor necrosis factor-a [TNF-a]), and, conversely, overstimulation of the proinflammatory response, plays a role in altered intestinal permeability and this may be associated with AIEC expansion and pathogenesis. 22, [29] [30] [31] A key mediator of signaling by many cytokines, NF-kB has been shown to regulate the development and response of the immune system, inflammation, and cancer. 32 Defective NF-kB activation can result in a defective immune cell response to BPs (driven by interleukin [IL]8) and bacterial lipopolysaccharides, and defective autophagy. [33] [34] [35] Taken together, dysfunctional regulation of proinflammatory cytokines may be associated with an inappropriate response to AIEC and may play a role in the promotion of AIEC expansion and pathogenesis.
AIEC Adherence
With respect to the clinical intersection between altered expression of genes in IBD and genes involved in AIEC expansion, patients who are at risk of developing CD also overexpress carcinoembryonic antigen-related cell-adhesion molecule 6 (CEACAM6), placing them at a higher risk for AIEC adherence and invasion via interaction of bacterial type 1 pili and long polar fimbriae (LPF) to host CEACAM6. 36 CEACAM6, normally expressed on the apical membrane of human epithelial cells from the large intestine, 37 is regulated by the proinflammatory cytokines IFN-g and TNF-a. 36, 38 Studies using isolated human Peyer's patches or mouse ileal biopsy specimens containing Peyer's patches showed that bacterial pili specifically targeted Peyer's patch M-cells (discussed later) expressing CEA-CAM6; however, LPF-independent AIEC invasion and adherence also has been shown in other types of intestinal epithelial cells. 36, 39 Nevertheless, AIEC can up-regulate CEACAM6 indirectly via activation of proinflammatory cytokines, 40 thus leading to increased expression of CEACAM6 and further binding and internalization of AIEC.
Carcinoembryonic antigen human bacterial artifical chromosome 10 (CEABAC10) transgenic mice that overexpress human CEACAMs show no clinical evidence of colitis; however, these same mice infected with AIEC show a barrier defect. 41 It would be expected, therefore, that patients with NOD2 mutations and/or increased expression of ileal CEACAM6 are more at risk to develop IBD. In support of this statement, CEACAM6 and the pore-forming TJ protein claudin-2, isolated from ileal biopsy specimens of CD patients, are not only co-localized, but expression levels are both increased compared with control subjects, 41 thereby promoting a favorable environment for AIEC adherence and invasion and further exacerbation of barrier dysfunction, ultimately leading to a vicious cycle of proinflammatory cytokine release and increased barrier permeability. Interestingly, although CEACAM6 is overexpressed in ileal mucosa of IBD patients, the protein is not normally expressed in ileal mucosa. 41 The mechanism(s) regulating CEACAM6 expression in IBD currently are not known.
AIEC Invasion
The mechanism of AIEC internalization involves macropinocytosis and vacuolization of the bacteria into IECs and macrophages.
9,42-44 AIEC have been found in late endosomes of intestinal epithelial cells, as evident by co-localization with the lysosomal marker lysosomal-associated membrane protein-1 (LAMP1). 24, 44 Similarly, Mycobacterium avium subspecies paratuberculosis has been localized in endosomes of intestinal epithelial cells. 45 The process of internalization into endosomes also occurs during reorganization of TJs and is discussed later. AIEC-containing endosomes mature into phagolysosomes, which then can exit IECs, as discussed later. Alternatively, AIEC replication is permitted in autophagolysisdeficient, AIEC-containing phagosome/endosome/lysosomes, leading to loss of organelle membrane integrity, release of the bacteria into the cytoplasm, and basolateral exit of the bacteria from the IEC (Figure 1) . 46, 47 AIEC translocation through the epithelial barrier is dependent on type 1 pili and binding of LPF to glycoprotein 2 (GP2) to AIEC Disruption of Epithelial Junctions microfold cells (M-cells). 39, 43, 48 M-cells are required for the development of host immunity, 49 are involved in bacterial sampling, [50] [51] [52] [53] and can serve as an alternative gateway for AIEC 39, 54 into and through the epithelium (reviewed by 55 ). The AIEC-containing endosome can mature into a phagosome and exit basolaterally from the IEC, where it can be processed by macrophages (Figure 1) . 42, 44 After basolateral exit from epithelial cells, AIEC exposure to lamina propria immune cells induces a proinflammatory response and a TNF-a-dependent increase in M-cell development, 56 thereby further permitting the adherence and invasion of AIEC and exacerbation of barrier permeability. AIEC invasion elicits a proinflammatory response by triggering secretion of proinflammatory cytokines from IECs, resulting in recruitment of immune cells, 13, 57 and, subsequently, NF-kB signaling, 13 which allows survival of AIEC in macrophages. 58 In summary, cytokines play a key role in the pathogenesis of AIEC and AIEC-induced epithelial barrier dysfunction.
AIEC-Dependent Disruption of the Apical Junctional Complex
In addition to the unknown etiology of IBD, it is uncertain whether inflammation precedes epithelial barrier dysfunction or if barrier dysfunction results in chronic inflammation such as that observed in IBD. However, some evidence points to an underlying barrier defect that renders individuals susceptible to disease. First-degree relatives of CD patients show asymptomatic barrier dysfunction associated with subclinical immune activation, indicating that a barrier defect may precede or is at least an early event in the disease. 59 , 60 In addition, altered permeability across the intestinal epithelium is a predictor of relapse in human CD 61 ; whereas increased permeability precedes inflammation in rodent models, 62 canine models, 63 and human disease, 59, [64] [65] [66] and has been shown to be the underlying mechanism of IBD in these patients. Thus, host health is dependent on the integrity of the epithelial barrier. Pathologic stimuli, such as AIEC, in part influence epithelial barrier integrity by altering the network of proteins that regulate barrier permeability known as the intercellular apical junctional complex (AJC). 67 The AJC, comprised of several different proteins with distinct responsibilities, directs the paracellular movement of ions and solutes and thus is responsible to maintain appropriate epithelial barrier permeability. The structural units of the AJC responsible for regulating barrier integrity and permeability are adherens junctions (AJ) and apical TJs. 17 AJs and TJs are associated with scaffolding proteins that cooperate with the cytoskeleton of the cell providing the AJC with a dynamic means of regulation. 67 Dysregulation of TJ proteins is observed in IBD patients (Table 1) . [68] [69] [70] [71] That the AJC is required for barrier integrity has led to the hypothesis that defects in the AJC may play a role in IBD pathogenesis. Alteration of the AJC can occur in response to exposure to AIEC and other enteropathogenic E coli. [71] [72] [73] [74] AIEC have been shown to decrease transepithelial electrical resistance of IECs owing to disruption of the AJC. 47, 67 The molecular interaction of AIEC with IECs induces an inflammatory response leading to the overproduction of proinflammatory cytokines, 75 with IFN-g and TNF-a as the major effectors, and this is a key step in the pathogenesis of IBD. IFN-g and TNF-a both have been shown to increase gut permeability by acting on TJ proteins and TJ strand complexity, 76, 77 which then further exacerbates barrier dysfunction. AIEC-dependent, cytokine-induced alterations in AJ and TJ proteins is discussed later.
CEACAM6
As previously discussed, an increase in expression of both CEACAM6 and claudin-2 is associated with increased barrier permeability. Interestingly, targeting of adherens junction proteins, occludin, and claudin 3/4 and other tight junction proteins by Helicobacter pylori, Vibrio cholera, and enteropathogenic E coli, respectively, has been shown previously, 78, 79 supporting the possibility that AIEC directly bind to TJ proteins. It has been shown that AIEC results in increased claudin-2 expression in mice and human beings, 41 and because AIEC pathogenesis is not dependent solely on interaction of CEACAM6 with AIEC, it is possible that claudin-2 could serve as a gateway for AIEC entry into IECs while co-internalization of TJ proteins and AIEC may promote AIEC invasion and increased barrier permeability. Whether AIEC are able to bind directly to TJ proteins has yet to be shown experimentally.
Claudin-2
Distinct from the functions of adherens junctions, TJs serve as a paracellular gateway for passive fluid movement and solute flux and limit the passive movement of proteins and lipids, thereby generating a concentration gradient as well as playing a role in polarization of epithelia. 71 The conglomeration of proteins that make up the TJs include the claudin family of transmembrane proteins, junctional adhesion molecule-A (JAM-A), occludin, and zonula occludens members 1-3 (others not included in this article are reviewed elsewhere 67 ) (Figure 1 ). Claudin-2 is a prominent member of the claudin family because it forms a cation-selective pore that permits paracellular sodium and water flux. 80, 81 Overexpression of claudin-2 results in an increase in epithelial barrier permeability both in vitro and in vivo. [82] [83] [84] [85] IL13 and TNF-a induce a barrier defect in UC by up-regulating claudin-2 to facilitate the pore pathway, although IL6 also has been shown to increase claudin-2 expression in intestinal epithelial cells. 86, 87 That epithelial barrier leakiness is related inversely to TJ strand complexity 67 supports the association of increased levels of claudin-2 with increased barrier permeability in IBD. 70, 88 Conversely, a decrease in claudin-2 expression results in a tighter epithelial barrier. 89 
E-cadherin
Adherens junctions are primarily responsible for cell-cell recognition as well as initiating and maintaining cell-cell contact and polarization. 90 The major AJ protein is E-cadherin, a transmembrane protein associated with the catenin family of cytoplasmic proteins (Figure 1) . 90 E-cadherin plays a critical role in adhesion of cells and is required for the formation of TJs.
91 E-cadherin single-nucleotide polymorphisms and dysregulation of E-cadherin are associated with IBD (reviewed by McCole   91 ), supporting a role for AJ defects in IBD-associated barrier dysfunction. 67 Furthermore, AIEC, in addition to other intestinal pathogens, 91 are able to displace E-cadherin in vitro, 47, 93 potentially providing another mechanism of invasion and barrier disruption.
Junctional Adhesion Molecule
JAM-A is another PSD95-DlgA-zonula occludens-1 homology domain (PDZ)-domain-containing integral protein localized to TJs. 98 JAM-A shows PDZ-domain-dependent interactions with the scaffolding protein zonula occludens 1 (ZO-1) and cell polarity partitioning defective protein-3. 99 Expression of JAM-A was shown to be decreased 69 together with ZO-1 100 in IBD, and loss of JAM-A results in increased epithelial barrier permeability. 101, 102 It is unknown whether AIEC directly results in the down-regulation of JAM-A or if it is a consequence of down-regulation of ZO-1; however, AIEC may regulate JAM-A indirectly via the release of inflammatory cytokines from infected macrophages. 94 Nevertheless, it is possible that AIEC, in addition to altering ZO-1, may alter JAM-A and partitioning defective protein-3-dependent targeting of TJ proteins to the membrane, 97 resulting in disrupted TJ complex integrity and altered cell polarity, further promoting IBD pathogenesis.
Occludin
Occludin, a 65-kilodalton integral transmembrane protein, is involved in the stability and regulation of TJs. Although down-regulation of occludin is observed in CD and UC patients, 69 the UC-associated proinflammatory cytokine IL13 alone was not able to abolish occludin protein levels in a colorectal cancer cell line (HT-29). 86 This discrepancy was attributed to a dilution of the number of cells isolated from the inflamed tissue of UC patients. Nevertheless, it has been shown from in vitro work that occludin plays a key role in promoting barrier function and is redistributed away from tight junctions after enterohemorrhagic E coli infection of human colonoid monolayers. 17, 74 Further work to elucidate the in vivo role of occludin is needed because mice lacking occludin do not show defects in TJ morphology despite histologic abnormalities in some tissues. 104 Proinflammatory cytokine-dependent phosphorylation of myosin light chain (MLC) by myosin light chain kinase (MLCK) or Rho-associated kinase results in rapid reorganization of the AJC. 67, 96, 105 Although it remains to be confirmed, AIEC could affect occludin distribution indirectly through bacteriadependent induction of proinflammatory cytokines from immune cells, activation of MLCK or Rho-associated kinase, and subsequent redistribution of occludin.
Zonula Occludens
ZO is a PDZ homology domain containing plaque protein involved in scaffolding of TJ proteins to the cytoskeleton. 106 ZO-1, -2, and -3 contain PDZ domains that facilitate anchorage of TJ proteins such as claudins, 107 occludin, 108 and JAM-A 100 to the cytoplasm and thereby play a key role in TJ formation and regulation. TNF-a induces an increase in TJ permeability via NF-kB-dependent down-regulation of ZO-1 protein and MLCK-dependent 95, 96, [109] [110] [111] redistribution of TJ proteins 76 in an apoptosis-independent manner (reviewed by Bruewer et al 67 ). Similarly, AIEC disrupt TJ composition by altering ZO-1, resulting in increased appearance of gaps between cells. 47, 93 Conversely, probiotic and commensal bacteria promote up-regulation of ZO proteins and strengthening of the epithelial barrier (reviewed by Ulluwishewa et al 112 ), potentially supporting the notion that when probiotic bacteria outcompete pathogens, this not only will return the balance of the microbiota, but also enable restitution of the TJ complex.
In the absence of bacteria, regulation of the AJC is mediated by the interaction of the cytoskeleton with the proteins of the AJC or by cytokines. IFN-g induces macropinocytosis 92 of occludin, JAM-A, and claudin-1 via myosin 2-dependent vacuolarization of the apical membrane 105 into early endosomes, resulting in an increase in barrier permeability. 113 That AIEC also are internalized by macropinocytosis illustrates a direct disruption of the AJC by the bacteria and establishes an additional virulence factor for the invasion of AIEC.
Conclusions
Data to date clearly support the notion that IBD pathogenesis is dependent on dysregulation of multiple factors including disruption of the intestinal barrier and immune dysregulation, and is associated with profound alterations in gut microbial communities. Altered intestinal homeostasis drives expansion of AIEC and results in compromised barrier function. AIEC are able to invade, survive, and replicate within host cells, leading to exacerbation of barrier dysfunction by disruption of TJ proteins, and ultimately contributing to IBD pathogenesis. Recent clinical findings have indicated that AIEC is not associated exclusively with ileal CD. If AIEC does indeed play an important role in IBD pathogenesis it will be vital to better understand unresolved questions regarding its appearance in disease. Specifically: (1) what are the host genetic and environmental factors that promote AIEC expansion in some patients but not all; (2) how is regional variation in AIEC expansion determined; and (3) can therapeutic interventions (probiotics, prebiotics, small molecules) specifically neutralize or modify AIEC pathogenic behavior? AIEC are capable of compromising intestinal epithelial barrier properties both directly and indirectly to enhance their pathogenic impact. Therefore, in addition to the earlier-described approaches, it will be of key interest to determine if strategies designed to enhance the epithelial barrier can minimize the pathogenic impact of AIEC and its putative contribution to IBD.
